In the HealthBIO – Red Biotech, Kuopio is profiling especially in the fields of:
- Molecular Medicine
- Drug Development
- Clinical Research
The strength of Kuopio is the multidisciplinary approach towards human health and wellbeing, especially in serious public health problems including prevention, diagnostics and treatment. The wide-range top expertise is mainly based on the University's biosciences and health and wellbeing sciences but also utilizes the core expertise from other institutes and commercial organizations in the community. The commercial activities pursued in Kuopio are mainly in the service sector, contract manufacturing and pharmaceutical drug development. There is also ground-breaking work being done in the commercialization of gene therapy, neurology and diagnostics.
The major objective of these activities is to develop a business environment favourable for birth of novel enterprise activities, to encourage growth of the existing business and to promote internationalization as well as intensifying the innovation environment. We also aim to develop and support local expertise and increase the consiousness and attractiveness of the bio/medicine field.
Kuopio Innovation Ltd. belongs to the national HealthBio Red Biotech Competence Cluster together with Oulu Innovation Ltd, Culminatum Ltd Oy (Espoo), Finn-Medi Research Ltd (Tampere) and Turku Science Park Ltd.. More information can be obtained from the Cluster's homepage: www.healthbio.fi.
- Brochures, reports and other publications
- Companies s co-operating with Kuopio Innovation Ltd. in HealthBIO sector
For more information
Marja Jaurakkajärvi, Development Director
Mobile: +358 45 139 3992